PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

UT MD Anderson scientists find protein that reins in runaway network

OTUD7B protects enzyme that controls pathway tied to autoimmune disease, cancer

2013-01-23
(Press-News.org) HOUSTON — Marked for death with molecular tags that act like a homing signal for a cell's protein-destroying machinery, a pivotal enzyme is rescued by another molecule that sweeps the telltale targets off in the nick of time.

The enzyme, called TRAF3, lives on to control a molecular network that's implicated in a variety of immune system-related diseases if left to its own devices.

The University of Texas MD Anderson scientists identified TRAF3's savior and demonstrated how it works in a paper published online Sunday in Nature.

By discovering the role of OTUD7B as TRAF3's protector, Shao-Cong Sun, Ph.D., professor in MD Anderson's Department of Immunology, and colleagues filled an important gap in their understanding of a molecular pathway discovered in Sun's lab.

"Genetic defects or constant degradation of TRAF3 lead to the uncontrolled activity of what we call the non-canonical NF-kB pathway. This in turn, is associated with autoimmune diseases and lymphoid malignancies such as multiple myeloma and B cell lymphomas," Sun said. "Understanding how the degradation of TRAF3 is regulated is extremely important."

Dodging annihilation, turning the tables

Sun earlier found an alternative, or non-canonical, pathway that activates the protein complex known as NF-kB, a family of proteins that turns on genes that are important in immune response, inflammation, cell growth and survival, and development.

They found that NF-kB activity increases when TRAF3 has the homing targets, called ubiquitins, attached to it and is destroyed by the proteasome, a complex of proteins that hunts down ubiquitin-decorated proteins.

When TRAF3 evades attack, it turns that same destructive mechanism against NIK, a protein that's central to NF-kB activity, by tagging it with ubiquitins.

The key question was: What regulates TRAF3's destruction and, in the process, controls NF-kB?

OTUD7B emerges

Sun and colleagues had a candidate, the enzyme OTUD7B, also known by its more lyrical name, Cezanne. It was genetically quite similar to another enzyme active in the canonical pathway for NF-kB called A20. Both were known deubiquitinases, enzymes that cleave ubiquitin polymers. A20 is not active in the non-canonical NFkB pathway.

By applying inducers of the non-canonical NK-kB pathway to cells derived from OTUD7B-deficient mice, the researchers found:

Degradation of TRAF3 and accumulation of its target, NIK Ubiquitination of TRAF3

Cells with OTUD7B intact suppressed non-canonical NF-kB signaling.

Varied immune effects in mice

Knocking out the OTUD7B gene caused biological changes in mice, but it did not kill them, as occurs when A20 is knocked out.

Mice with OTUD7B suppressed had greatly increased lymphoid cell growth in the lining of the intestine and hyper-responsiveness to antigens by B cells. "If these two symptoms occur persistently, as they did in the knockout mice, they may contribute to autoimmunity or inflammation," Sun said.

However, knockout mice also had an improved immune response to the lethal intestinal bacterial pathogen C. rodentium. All of the mice with normal OTUD7B died of the bacterial infection, while 75 percent of the knockout mice survived.

Teasing out the reasons for these effects and developing OTUD7B as a target for inhibitors to boost immunity in the lining of the intestine will take more research, Sun said.

"It's important to know that TRAF3 has opposing roles in regulating activation of T cells and B cells, indicating that OTUD7B has a cell-type specific function. So, as with many other research findings, it might take considerably more effort to assess the therapeutic potential of OTUD7B," Sun said.

###

Co-authors with Sun are first author Hongbo Hu, George Brittain, Jae-Hoon Chang, Nahum Puebla-Osorio, Jin Jin, Anna Zal, Yichuan Xiao, Xuhong Cheng, Mikyoung Chang, Tomasz Zal, and Chengming Zhu; and Yang-Xin Fu, of the University of Chicago. Zal, Zhu and Sun also are affiliated with The University of Texas Graduate School of Biomedical Sciences at Houston.

This study was supported by grants from the National Institutes of Health (numbers AI057555, AI064639, GM84459, CA137059, and T32CA009598), including MD Anderson's NCI Cancer Center Support Grant and the Sister Institution Network Fund of MD Anderson Cancer Center.

About MD Anderson

The University of Texas MD Anderson Cancer Center in Houston ranks as one of the world's most respected centers focused on cancer patient care, research, education and prevention. MD Anderson is one of only 41 comprehensive cancer centers designated by the National Cancer Institute. For nine of the past 11 years, including 2012, MD Anderson has ranked No. 1 in cancer care in "America's Best Hospitals," a survey published annually in U.S. News & World Report.

END



ELSE PRESS RELEASES FROM THIS DATE:

NYUCN's Drs. Shedlin and Anastasi publish in the Journal of the Association of Nurses in AIDS Care

2013-01-23
New York University College of Nursing (NYUCN) researchers Michele G. Shedlin, PhD, and Joyce K. Anastasi, PhD, DrNP, FAAN, LAc, published a paper, "Use of Complementary and Alternative Medicines and Supplements by Mexican-Origin Patients in a U.S.–Mexico Border HIV Clinic," in the on-line version of the Journal of the Association of Nurses in AIDS Care. Complementary and alternative medicines (CAM) and therapies are often used to improve or maintain overall health and to relieve the side effects of conventional treatments or symptoms associated with chronic illnesses ...

TGen, Scottsdale Healthcare study shows drug combination extends pancreatic cancer patient survival

2013-01-23
SCOTTSDALE, Ariz. — Jan. 22, 2013 — A multi-center Phase III clinical trial demonstrates that Abraxane (nab-paclitaxel) plus gemcitabine is the first combination of cancer drugs to extend survival of late-stage pancreatic cancer patients compared to standard treatment. The MPACT (Metastatic Pancreatic Adenocarcinoma Clinical Trial) study was led by physicians from Scottsdale Healthcare's Virginia G. Piper Cancer Center Clinical Trials, a partnership between Scottsdale Healthcare and the Translational Genomics Research Institute (TGen). Their findings show that Abraxane ...

BPA substitute could spell trouble

2013-01-23
A few years ago, manufacturers of water bottles, food containers, and baby products had a big problem. A key ingredient of the plastics they used to make their merchandise, an organic compound called bisphenol A, had been linked by scientists to diabetes, asthma and cancer and altered prostate and neurological development. The FDA and state legislatures were considering action to restrict BPA's use, and the public was pressuring retailers to remove BPA-containing items from their shelves. The industry responded by creating "BPA-free" products, which were made from plastic ...

A call to prevent unsafe high-risk medical devices from reaching the marketplace

A call to prevent unsafe high-risk medical devices from reaching the marketplace
2013-01-23
Technological advancements in medicine have allowed patients suffering from musculoskeletal conditions such as hip and knee pain to regain mobility and live relatively pain-free. But some "high risk" surgical devices that have been approved by the U.S. Food and Drug Administration (FDA) are not required to go through clinical trials, where a product is tested to determine its safety and effectiveness. "This could be potentially very dangerous. Many Americans – patients and even physicians - are not aware of how many devices in this country are on the market without having ...

New study reveals sex to be pleasurable with or without use of a condom or lubricant

2013-01-23
A new study published in The Journal of Sexual Medicine reveals that within a nationally representative study of American men and women, sex was rated as highly arousing and pleasurable whether or not condoms and/or lubricants were used. Condoms and lubricants are commonly used by both women and men when they have sex. Led by Debby Herbenick, PhD, MPH and Michael Reece, PhD, MPH, of the School of Public Health-Bloomington, Indiana University, researchers reviewed a nationally representative study of men and women in the United States ages 18-59 to assess characteristics ...

Can changes in nutrition labeling help consumers make better food choices?

2013-01-23
AUDIO: An FDA-commissioned study finds that two proposed nutrition labeling changes could potentially make nutritional content information easier to understand. Study participants could more accurately assess the number of calories or... Click here for more information. Philadelphia, PA, January 23, 2013 – The Nutrition Facts label was introduced 20 years ago and provides consumers with important information, including: the serving size, the number of servings in the package, the ...

Moffitt study shows smoking cessation more successful for cancer patients who quit before surgery

2013-01-23
Lung and head and neck cancer patients who smoked before surgery are more likely to relapse than those who had quit before surgery, Moffitt Cancer Center researchers say. They found that smoking-relapse prevention interventions are needed immediately after surgery to help prevent relapse. The study was published in a recent issue of the journal Cancer. "Cigarette smoking is responsible for 30 percent of all cancer-related mortalities," said study corresponding author Vani Nath Simmons, Ph.D., assistant member of the Health Outcomes and Behavior Program at Moffitt. "Head ...

A French-Peruvian-Spanish Team Discovers a (Burial?) Chamber in Machu Picchu

2013-01-23
For more than fifteen years, Thierry Jamin, French Archaeologist and adventurer, explores the jungles of South Peru in every possible direction, searching for clues of the permanent presence of the Incas in the Amazonian forest, and the legendary lost city of Paititi. After the discovery of about thirty incredible archeological sites, located in the North of the department of Cuzco, between 2009 and 2011, which include several fortresses, burial and ceremonial, centers, and small Inca cities composed by hundreds of buildings, and many streets, passages, squares..., Thierry ...

Rich Von in Talks for $30 Million Rental Fund

2013-01-23
Rich Von, one of the partners of Von Vesting, Inc., is excited to announce that the company is in high-level talks to take on a $30 million rental fund. If the fund goes through, Rich Von says the company will have achieved part one of its goal to reach $100 million in rental properties. As Rich Von explains, each $10 million fund represents about 110 single-family residences. The company has always put an emphasis on choosing the best properties for an area, including in its criteria the possibilities of improved economic development of that area. While Rich Von is ...

Gatlinburg Falls Resort Wins Three Straight Talk of the Town Customer Satisfaction Awards

2013-01-23
With a customer satisfaction rating of 4.5 stars in 2012, Gatlinburg Falls Resort has won the prestigious CMUS Talk of the Town Customer Satisfaction Award for the third consecutive year in the Hotels & Travel category. The Talk of the Town Awards, presented by Talk of the Town News, Customer Care News magazine and Celebration Media U.S. (CMUS), honor companies and professionals that provide excellent customer service as reported by their customers through no-cost, user-review websites, blogs, social networks, business rating services, and other honors and accolades. ...

LAST 30 PRESS RELEASES:

Reality check: making indoor smartphone-based augmented reality work

Overthinking what you said? It’s your ‘lizard brain’ talking to newer, advanced parts of your brain

Black men — including transit workers — are targets for aggression on public transportation, study shows

Troubling spike in severe pregnancy-related complications for all ages in Illinois

Alcohol use identified by UTHealth Houston researchers as most common predictor of escalated cannabis vaping among youths in Texas

Need a landing pad for helicopter parenting? Frame tasks as learning

New MUSC Hollings Cancer Center research shows how Golgi stress affects T-cells' tumor-fighting ability

#16to365: New resources for year-round activism to end gender-based violence and strengthen bodily autonomy for all

Earliest fish-trapping facility in Central America discovered in Maya lowlands

São Paulo to host School on Disordered Systems

New insights into sleep uncover key mechanisms related to cognitive function

USC announces strategic collaboration with Autobahn Labs to accelerate drug discovery

Detroit health professionals urge the community to act and address the dangers of antimicrobial resistance

3D-printing advance mitigates three defects simultaneously for failure-free metal parts 

Ancient hot water on Mars points to habitable past: Curtin study

In Patagonia, more snow could protect glaciers from melt — but only if we curb greenhouse gas emissions soon

Simplicity is key to understanding and achieving goals

Caste differentiation in ants

Nutrition that aligns with guidelines during pregnancy may be associated with better infant growth outcomes, NIH study finds

New technology points to unexpected uses for snoRNA

Racial and ethnic variation in survival in early-onset colorectal cancer

Disparities by race and urbanicity in online health care facility reviews

Exploring factors affecting workers' acquisition of exercise habits using machine learning approaches

Nano-patterned copper oxide sensor for ultra-low hydrogen detection

Maintaining bridge safer; Digital sensing-based monitoring system

A novel approach for the composition design of high-entropy fluorite oxides with low thermal conductivity

A groundbreaking new approach to treating chronic abdominal pain

ECOG-ACRIN appoints seven researchers to scientific committee leadership positions

New model of neuronal circuit provides insight on eye movement

Cooking up a breakthrough: Penn engineers refine lipid nanoparticles for better mRNA therapies

[Press-News.org] UT MD Anderson scientists find protein that reins in runaway network
OTUD7B protects enzyme that controls pathway tied to autoimmune disease, cancer